Heston W D, Kadmon D, Fair W R
Cancer Lett. 1981 Jul;13(2):139-45. doi: 10.1016/0304-3835(81)90140-3.
The R3327 MAT-LyLu, a lymphotrophic, metastatic prostate-derived rat tumor was treated with high dose diethylstilbestrol or the chemotherapeutic agent ICRF-159. Both drugs inhibited the growth of the primary tumor and the development of metastases.
R3327 MAT-LyLu是一种源自前列腺的具有亲淋巴细胞性、转移性的大鼠肿瘤,用高剂量己烯雌酚或化疗药物ICRF-159对其进行治疗。两种药物均抑制原发肿瘤的生长和转移的发生。